Skip to main content

Opinion: Invisible middlemen are slowing down American healthcare

By The Atlantic  
   April 09, 2019

Lynn Lear finished her final round of chemotherapy for breast cancer in December. To help keep the cancer from coming back, Lear’s doctor told her about a new medication she could take called Nerlynx. Lear, who is 46, wanted to do everything she could to remain healthy, so she asked her doctor to order the drug for her.

Full story


Get the latest on healthcare leadership in your inbox.